Back to Search
Start Over
108P Pembrolizumab in pre-treated advanced non-small cell lung cancer (NSCLC) patients (pts): Impact of blood-based biomarkers on survival outcomes.
- Source :
-
Annals of Oncology . 2020 Supplement 4, Vol. 31, pS284-S284. 1p. - Publication Year :
- 2020
- Subjects :
- *NON-small-cell lung carcinoma
*SURVIVAL rate
*PEMBROLIZUMAB
*BIOMARKERS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152694812
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.08.229